مراجعة
Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer.
| العنوان: | Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer. |
|---|---|
| المؤلفون: | Bullock, Kennady K, Richmond, Ann |
| المصدر: | Cancers (Basel) ; ISSN:2072-6694 ; Volume:16 ; Issue:12 |
| بيانات النشر: | MDPI |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | PD-1, PD-L1, PI3K/AKT, RAS/MAPK/ERK, immune checkpoint inhibition, triple-negative breast cancer |
| الوصف: | The introduction of anti-programmed cell death protein-1 (anti-PD-1) to the clinical management of triple-negative breast cancer (TNBC) represents a breakthrough for a disease whose treatment has long relied on the standards of chemotherapy and surgery. Nevertheless, few TNBC patients achieve a durable remission in response to anti-PD-1, and there is a need to develop strategies to maximize the potential benefit of immune checkpoint inhibition (ICI) for TNBC patients. In the present review, we discuss three conceptual strategies to improve ICI response rates in TNBC patients. The first effort involves improving patient selection. We discuss proposed biomarkers of response and resistance to anti-PD-1, concluding that an optimal biomarker will likely be multifaceted. The second effort involves identifying existing targeted therapies or chemotherapies that may synergize with ICI. In particular, we describe recent efforts to use inhibitors of the PI3K/AKT or RAS/MAPK/ERK pathways in combination with ICI. Third, considering the possibility that targeting the PD-1 axis is not the most promising strategy for TNBC treatment, we describe ongoing efforts to identify novel immunotherapy strategies. |
| نوع الوثيقة: | review article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.3390/cancers16122189Test; https://pubmed.ncbi.nlm.nih.gov/38927895Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11201651Test/ |
| DOI: | 10.3390/cancers16122189 |
| الإتاحة: | https://doi.org/10.3390/cancers16122189Test https://pubmed.ncbi.nlm.nih.gov/38927895Test https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11201651Test/ |
| رقم الانضمام: | edsbas.93D200EF |
| قاعدة البيانات: | BASE |
| DOI: | 10.3390/cancers16122189 |
|---|